Peres Jepchirchir Suspended by AIU After Positive EPO Test

On August 30, 2026, Peres Jepchirchir won the Sydney Marathon in 2:18:31, finishing more than three minutes clear of her compatriot Irene Chepet Cheptai. It was another signature result in a career that already included Olympic and world championship gold medals. That victory is now under official scrutiny. The Athletics Integrity Unit (AIU) has provisionally suspended the 33-year-old Kenyan after an out-of-competition sample she provided in Kenya before the race tested positive for EPO. Erythropoietin, or EPO, is a hormone produced by the kidneys that stimulates the production of red blood cells. When injected, it increases the blood's oxygen-carrying capacity, which can improve endurance performance. It is also difficult to detect: the substance remains in urine or blood for only a short window, which is why testing around training blocks matters as much as race-day testing. The timeline is crucial here. The positive finding is not from a sample taken after the Sydney race. It came from an out-of-competition test conducted in Kenya before the race. Under World Athletics rules, Jepchirchir has the right to request analysis of her B-sample and to present her case at a hearing. Until then, she is provisionally suspended — a standard step, not a final verdict. Jepchirchir is not a peripheral figure in the sport. She won the Olympic women's marathon at the Tokyo 2026 Games and returned to Tokyo in September 2026 to claim the World Championships title. She broke the half-marathon world record in 2026 and improved it three times in 2026. Her major road victories include New York in 2026, Boston in 2026 and London in 2026. Sydney, which joined the World Marathon Majors as the seventh event in 2026, was the latest addition to that list. I remember watching her in 2026 when she rewrote the half-marathon record. At that moment, she looked like the leader of a new generation of Kenyan road runners — someone who raced with patience and finished with precision. Over the following years, she rarely produced a bad performance. That is part of why this case feels different: she has been one of the most consistent champions in the sport. But excellence and evidence are two separate things. A positive EPO finding is serious because EPO is not a casual supplement; it is a performance-enhancing method that requires deliberate use. Still, the procedural facts must be respected. Until the B-sample is analysed and a hearing is held, this remains a positive finding, not a proven violation. There is also a temptation to look at her 2:18:31 in Sydney and declare it chemically impossible without EPO. That would be a mistake. Performances in the 2:18 range are well within the natural capabilities of an elite marathoner. The time itself proves nothing. The test result is the only evidence that matters, and it must be examined on its own terms. This case will inevitably renew questions about Kenyan distance running, which has been hit by doping cases over the past decade. Those questions are fair, but they should not erase individual due process. Jepchirchir has not been found guilty of anything yet. Forcing her into a pre-written narrative would be as unfair as ignoring the finding. If the B-sample confirms the result and the AIU's case stands, the consequences would be direct: the Sydney title, prize money and results after the sample date could be annulled. Until then, the sporting world must hold two ideas at once — that the system works and that it remains open to challenge. This case is bigger than one runner. It is a test of whether marathon's most visible victories can be trusted not only as results but as clean performances. Jepchirchir is entitled to prove her innocence, and the AIU is obliged to prove its process. The next few weeks will decide which version of the story survives.